Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from BellRing Brands ( (BRBR) ) is now available.
BellRing Brands‘ subsidiary, Premier Nutrition, has been involved in multiple class action lawsuits concerning its Joint Juice product. On June 25, 2025, Premier Nutrition reached a settlement in principle to pay $90 million to resolve these claims. By October 2025, a Stipulation of Settlement was executed, and a motion for preliminary approval was filed, awaiting a decision.
The most recent analyst rating on (BRBR) stock is a Hold with a $34.00 price target. To see the full list of analyst forecasts on BellRing Brands stock, see the BRBR Stock Forecast page.
Spark’s Take on BRBR Stock
According to Spark, TipRanks’ AI Analyst, BRBR is a Neutral.
The overall stock score of 55 reflects significant financial challenges, particularly in terms of leverage and cash flow generation, despite strong revenue growth. Technical indicators suggest bearish momentum, adding to the cautious outlook. Valuation is reasonable, but the lack of a dividend yield may limit appeal to some investors. The earnings call provided a cautiously optimistic outlook, but this was not factored into the score due to the redistribution of weights.
To see Spark’s full report on BRBR stock, click here.
More about BellRing Brands
BellRing Brands operates in the nutrition industry, primarily focusing on health and wellness products. Its subsidiary, Premier Nutrition Company, LLC, is known for products like Joint Juice, which targets consumers seeking joint health benefits.
Average Trading Volume: 3,362,047
Technical Sentiment Signal: Sell
Current Market Cap: $4.22B
For detailed information about BRBR stock, go to TipRanks’ Stock Analysis page.